FDA Panel Votes Against Arena’s Diet Drug
Another diet drug, Arena Pharmaceuticals’s Iorcaserin, appears to be in danger after a U.S. Food and Drug Administration advisory panel voted to reject it Thursday.
Continue reading FDA Panel Votes Against Aren…